| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Models, Genetic | 31 | 2023 | 948 | 4.760 |
Why?
|
| Single-Cell Analysis | 6 | 2025 | 156 | 3.280 |
Why?
|
| Polymorphism, Single Nucleotide | 37 | 2024 | 2415 | 3.280 |
Why?
|
| Genome-Wide Association Study | 23 | 2024 | 1691 | 2.910 |
Why?
|
| Genetics, Population | 17 | 2019 | 407 | 2.610 |
Why?
|
| Bayes Theorem | 22 | 2023 | 381 | 2.590 |
Why?
|
| Sequence Analysis, RNA | 12 | 2025 | 241 | 2.500 |
Why?
|
| Software | 13 | 2024 | 669 | 2.330 |
Why?
|
| Algorithms | 19 | 2024 | 1908 | 2.090 |
Why?
|
| Models, Statistical | 10 | 2020 | 576 | 1.790 |
Why?
|
| Genomics | 7 | 2020 | 778 | 1.560 |
Why?
|
| Genetic Variation | 20 | 2021 | 1380 | 1.480 |
Why?
|
| Gene Expression Regulation | 19 | 2021 | 1983 | 1.470 |
Why?
|
| Gene Expression Profiling | 16 | 2025 | 1452 | 1.450 |
Why?
|
| Haplotypes | 13 | 2019 | 637 | 1.380 |
Why?
|
| Genome | 7 | 2020 | 391 | 1.270 |
Why?
|
| Genotype | 20 | 2023 | 1853 | 1.240 |
Why?
|
| Data Interpretation, Statistical | 4 | 2019 | 302 | 1.200 |
Why?
|
| Quantitative Trait Loci | 19 | 2024 | 615 | 1.190 |
Why?
|
| Linkage Disequilibrium | 7 | 2022 | 477 | 1.170 |
Why?
|
| Elephants | 4 | 2015 | 17 | 1.160 |
Why?
|
| Recombination, Genetic | 11 | 2018 | 446 | 1.090 |
Why?
|
| Phenotype | 16 | 2024 | 2457 | 1.010 |
Why?
|
| Genome, Human | 13 | 2018 | 791 | 0.900 |
Why?
|
| Genetic Techniques | 4 | 2008 | 73 | 0.900 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2025 | 120 | 0.870 |
Why?
|
| Gene Expression | 9 | 2023 | 1309 | 0.810 |
Why?
|
| Principal Component Analysis | 5 | 2024 | 161 | 0.710 |
Why?
|
| Humans | 82 | 2025 | 89924 | 0.690 |
Why?
|
| DNA | 5 | 2018 | 1311 | 0.680 |
Why?
|
| Computational Biology | 4 | 2020 | 551 | 0.650 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2025 | 1283 | 0.650 |
Why?
|
| Workflow | 1 | 2019 | 81 | 0.650 |
Why?
|
| Pancreatic Neoplasms | 1 | 2025 | 684 | 0.630 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 5 | 2015 | 377 | 0.620 |
Why?
|
| Information Dissemination | 1 | 2019 | 116 | 0.620 |
Why?
|
| Computer Simulation | 11 | 2023 | 1102 | 0.620 |
Why?
|
| Multivariate Analysis | 3 | 2019 | 983 | 0.600 |
Why?
|
| Sequence Alignment | 1 | 2018 | 354 | 0.590 |
Why?
|
| Transcriptome | 7 | 2024 | 661 | 0.580 |
Why?
|
| Population | 2 | 2008 | 36 | 0.580 |
Why?
|
| DNA Damage | 1 | 2019 | 373 | 0.560 |
Why?
|
| Chromosome Mapping | 8 | 2020 | 1074 | 0.540 |
Why?
|
| Linear Models | 2 | 2014 | 421 | 0.510 |
Why?
|
| Response Elements | 1 | 2015 | 69 | 0.500 |
Why?
|
| Population Dynamics | 2 | 2019 | 138 | 0.490 |
Why?
|
| Microsatellite Repeats | 4 | 2015 | 148 | 0.490 |
Why?
|
| Alleles | 7 | 2018 | 1139 | 0.490 |
Why?
|
| Lipoproteins, LDL | 1 | 2015 | 85 | 0.490 |
Why?
|
| Amino Acid Substitution | 1 | 2015 | 338 | 0.470 |
Why?
|
| Multifactorial Inheritance | 3 | 2024 | 173 | 0.460 |
Why?
|
| Cluster Analysis | 3 | 2023 | 371 | 0.450 |
Why?
|
| Interleukin-2 | 1 | 2013 | 241 | 0.420 |
Why?
|
| RNA | 1 | 2017 | 583 | 0.420 |
Why?
|
| Carcinoma | 1 | 2015 | 438 | 0.400 |
Why?
|
| Mutation | 6 | 2019 | 4165 | 0.400 |
Why?
|
| Arabidopsis | 1 | 2015 | 322 | 0.400 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 294 | 0.380 |
Why?
|
| Reproducibility of Results | 5 | 2022 | 2767 | 0.380 |
Why?
|
| Emigration and Immigration | 3 | 2008 | 48 | 0.370 |
Why?
|
| Likelihood Functions | 4 | 2022 | 252 | 0.350 |
Why?
|
| Crossing Over, Genetic | 2 | 2006 | 33 | 0.340 |
Why?
|
| Evolution, Molecular | 6 | 2018 | 854 | 0.340 |
Why?
|
| Transcription Factors | 5 | 2015 | 1665 | 0.340 |
Why?
|
| Diploidy | 2 | 2007 | 31 | 0.340 |
Why?
|
| Databases, Genetic | 6 | 2012 | 269 | 0.330 |
Why?
|
| Mathematical Computing | 1 | 2008 | 21 | 0.320 |
Why?
|
| Gene-Environment Interaction | 3 | 2018 | 118 | 0.320 |
Why?
|
| Induced Pluripotent Stem Cells | 3 | 2020 | 120 | 0.310 |
Why?
|
| Gene Frequency | 3 | 2015 | 687 | 0.310 |
Why?
|
| Genetic Markers | 2 | 2007 | 476 | 0.310 |
Why?
|
| Primates | 4 | 2018 | 155 | 0.300 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2013 | 565 | 0.300 |
Why?
|
| Genetics, Medical | 1 | 2008 | 52 | 0.300 |
Why?
|
| Genetic Heterogeneity | 2 | 2025 | 67 | 0.290 |
Why?
|
| Selection, Genetic | 6 | 2018 | 515 | 0.290 |
Why?
|
| Commerce | 1 | 2007 | 31 | 0.280 |
Why?
|
| Gene Conversion | 1 | 2006 | 24 | 0.280 |
Why?
|
| Monte Carlo Method | 3 | 2015 | 186 | 0.280 |
Why?
|
| Crohn Disease | 1 | 2013 | 764 | 0.280 |
Why?
|
| Animals | 21 | 2024 | 27526 | 0.270 |
Why?
|
| Artifacts | 1 | 2008 | 246 | 0.270 |
Why?
|
| Transcription, Genetic | 5 | 2017 | 1158 | 0.260 |
Why?
|
| RNA, Messenger | 6 | 2020 | 2026 | 0.260 |
Why?
|
| Simvastatin | 4 | 2014 | 105 | 0.260 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2020 | 490 | 0.250 |
Why?
|
| Dentin | 1 | 2004 | 7 | 0.240 |
Why?
|
| Neoplasms | 3 | 2019 | 3065 | 0.240 |
Why?
|
| Polymorphism, Genetic | 5 | 2012 | 825 | 0.240 |
Why?
|
| Regression Analysis | 2 | 2018 | 591 | 0.240 |
Why?
|
| Amidinotransferases | 2 | 2014 | 5 | 0.230 |
Why?
|
| Africa | 4 | 2010 | 101 | 0.230 |
Why?
|
| Cell Line | 10 | 2021 | 2495 | 0.230 |
Why?
|
| Geography | 5 | 2008 | 227 | 0.220 |
Why?
|
| Muscular Diseases | 2 | 2014 | 64 | 0.220 |
Why?
|
| Models, Biological | 4 | 2019 | 1765 | 0.210 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2024 | 2362 | 0.210 |
Why?
|
| Deoxyribonuclease I | 2 | 2012 | 28 | 0.200 |
Why?
|
| Biological Evolution | 3 | 2019 | 974 | 0.200 |
Why?
|
| Markov Chains | 4 | 2013 | 128 | 0.200 |
Why?
|
| Sequence Analysis, DNA | 5 | 2019 | 869 | 0.200 |
Why?
|
| Genetic Linkage | 1 | 2003 | 624 | 0.190 |
Why?
|
| Models, Theoretical | 2 | 2015 | 493 | 0.190 |
Why?
|
| Glucocorticoids | 3 | 2013 | 357 | 0.190 |
Why?
|
| Poisson Distribution | 1 | 2021 | 50 | 0.190 |
Why?
|
| Genetic Pleiotropy | 1 | 2020 | 25 | 0.170 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2020 | 44 | 0.170 |
Why?
|
| Cytokines | 1 | 2024 | 811 | 0.170 |
Why?
|
| Sepsis | 1 | 2024 | 329 | 0.170 |
Why?
|
| Terminology as Topic | 1 | 2021 | 222 | 0.170 |
Why?
|
| Tropical Climate | 1 | 2019 | 31 | 0.170 |
Why?
|
| Promoter Regions, Genetic | 3 | 2020 | 961 | 0.160 |
Why?
|
| DNA, Ancient | 1 | 2019 | 18 | 0.160 |
Why?
|
| Oncogenes | 1 | 2019 | 97 | 0.160 |
Why?
|
| Animal Distribution | 1 | 2019 | 22 | 0.160 |
Why?
|
| Polyploidy | 1 | 2018 | 18 | 0.160 |
Why?
|
| DNA Transposable Elements | 2 | 2018 | 175 | 0.160 |
Why?
|
| Coffea | 1 | 2018 | 2 | 0.160 |
Why?
|
| Molecular Sequence Annotation | 1 | 2018 | 71 | 0.150 |
Why?
|
| Europe | 4 | 2019 | 324 | 0.150 |
Why?
|
| Cytosine | 1 | 2019 | 130 | 0.150 |
Why?
|
| Cell Cycle | 1 | 2020 | 508 | 0.150 |
Why?
|
| Sex Characteristics | 1 | 2020 | 328 | 0.150 |
Why?
|
| Genotyping Techniques | 1 | 2018 | 69 | 0.150 |
Why?
|
| Myocytes, Cardiac | 1 | 2021 | 314 | 0.150 |
Why?
|
| Genome, Plant | 1 | 2018 | 96 | 0.150 |
Why?
|
| Myocardial Infarction | 1 | 2021 | 380 | 0.140 |
Why?
|
| Gene Silencing | 1 | 2018 | 178 | 0.140 |
Why?
|
| Adenosine | 1 | 2020 | 240 | 0.140 |
Why?
|
| Epigenesis, Genetic | 3 | 2020 | 521 | 0.140 |
Why?
|
| Birds | 1 | 2019 | 166 | 0.140 |
Why?
|
| Blastocyst | 1 | 2017 | 35 | 0.140 |
Why?
|
| Calibration | 2 | 2008 | 103 | 0.140 |
Why?
|
| Pan troglodytes | 3 | 2009 | 203 | 0.140 |
Why?
|
| Prognosis | 1 | 2025 | 3796 | 0.140 |
Why?
|
| Interleukin-6 | 2 | 2024 | 261 | 0.140 |
Why?
|
| Environment | 1 | 2018 | 225 | 0.130 |
Why?
|
| Base Sequence | 2 | 2018 | 2329 | 0.130 |
Why?
|
| Open Reading Frames | 1 | 2016 | 121 | 0.130 |
Why?
|
| Transients and Migrants | 1 | 2015 | 7 | 0.130 |
Why?
|
| Oxygen | 1 | 2021 | 745 | 0.130 |
Why?
|
| Molecular Biology | 1 | 2016 | 89 | 0.130 |
Why?
|
| Ribosomes | 1 | 2016 | 116 | 0.130 |
Why?
|
| Animal Migration | 1 | 2015 | 29 | 0.130 |
Why?
|
| India | 2 | 2019 | 125 | 0.130 |
Why?
|
| Hypoxia | 1 | 2021 | 657 | 0.130 |
Why?
|
| Exons | 3 | 2012 | 453 | 0.130 |
Why?
|
| Genes, Lethal | 1 | 2015 | 53 | 0.120 |
Why?
|
| Gene Flow | 1 | 2015 | 93 | 0.120 |
Why?
|
| Genes, Recessive | 1 | 2015 | 87 | 0.120 |
Why?
|
| Hybridization, Genetic | 1 | 2015 | 107 | 0.120 |
Why?
|
| Epigenomics | 1 | 2015 | 103 | 0.120 |
Why?
|
| Amino Acid Sequence | 1 | 2018 | 2063 | 0.120 |
Why?
|
| Papio | 1 | 2015 | 82 | 0.120 |
Why?
|
| RNA Stability | 2 | 2012 | 90 | 0.120 |
Why?
|
| Receptors, Glucocorticoid | 2 | 2013 | 135 | 0.120 |
Why?
|
| Protein Binding | 2 | 2015 | 1491 | 0.120 |
Why?
|
| DNA Mutational Analysis | 1 | 2015 | 529 | 0.110 |
Why?
|
| Asthma | 1 | 2022 | 984 | 0.110 |
Why?
|
| Protein Biosynthesis | 1 | 2016 | 389 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2013 | 23 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase 14 | 1 | 2013 | 6 | 0.110 |
Why?
|
| Male | 13 | 2020 | 42657 | 0.110 |
Why?
|
| Organ Specificity | 3 | 2020 | 277 | 0.110 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2004 | 143 | 0.110 |
Why?
|
| Interferon-gamma | 2 | 2024 | 449 | 0.110 |
Why?
|
| Helicobacter pylori | 2 | 2003 | 37 | 0.110 |
Why?
|
| Chromosomes, Human, X | 2 | 2020 | 55 | 0.100 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2017 | 663 | 0.100 |
Why?
|
| Population Groups | 1 | 2012 | 41 | 0.100 |
Why?
|
| DNA Modification Methylases | 1 | 2012 | 28 | 0.100 |
Why?
|
| DNA Footprinting | 1 | 2012 | 18 | 0.100 |
Why?
|
| Lipid Metabolism | 1 | 2013 | 201 | 0.100 |
Why?
|
| Species Specificity | 4 | 2018 | 685 | 0.100 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2013 | 171 | 0.100 |
Why?
|
| Female | 12 | 2021 | 46571 | 0.100 |
Why?
|
| Conservation of Natural Resources | 2 | 2015 | 83 | 0.100 |
Why?
|
| Molecular Epidemiology | 1 | 2011 | 54 | 0.100 |
Why?
|
| Cadherins | 1 | 2012 | 163 | 0.100 |
Why?
|
| Dextroamphetamine | 1 | 2012 | 108 | 0.090 |
Why?
|
| Population Density | 2 | 2019 | 61 | 0.090 |
Why?
|
| Signal Transduction | 2 | 2013 | 3403 | 0.090 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2012 | 154 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2013 | 346 | 0.090 |
Why?
|
| Factor Analysis, Statistical | 1 | 2010 | 114 | 0.090 |
Why?
|
| Homozygote | 2 | 2007 | 201 | 0.090 |
Why?
|
| Disease | 2 | 2020 | 90 | 0.080 |
Why?
|
| NF-kappa B | 1 | 2013 | 469 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2008 | 693 | 0.080 |
Why?
|
| Mice | 3 | 2024 | 11851 | 0.080 |
Why?
|
| Nigeria | 3 | 2019 | 157 | 0.080 |
Why?
|
| Dexamethasone | 1 | 2011 | 343 | 0.080 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 2587 | 0.080 |
Why?
|
| Sequence Deletion | 2 | 2006 | 205 | 0.080 |
Why?
|
| Transcription Initiation Site | 3 | 2017 | 46 | 0.080 |
Why?
|
| Case-Control Studies | 1 | 2013 | 1864 | 0.080 |
Why?
|
| Lipids | 1 | 2010 | 275 | 0.080 |
Why?
|
| Lymphocytes | 3 | 2016 | 468 | 0.080 |
Why?
|
| Alternative Splicing | 1 | 2009 | 212 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2008 | 79 | 0.080 |
Why?
|
| Quality Control | 1 | 2008 | 117 | 0.080 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2008 | 80 | 0.070 |
Why?
|
| Forests | 2 | 2019 | 23 | 0.070 |
Why?
|
| Macaca mulatta | 1 | 2009 | 467 | 0.070 |
Why?
|
| C-Reactive Protein | 1 | 2008 | 191 | 0.070 |
Why?
|
| Immunity, Innate | 1 | 2010 | 434 | 0.070 |
Why?
|
| DNA Methylation | 1 | 2012 | 666 | 0.070 |
Why?
|
| Genes, Neurofibromatosis 1 | 1 | 2006 | 2 | 0.070 |
Why?
|
| Crime | 1 | 2007 | 37 | 0.070 |
Why?
|
| Brain | 1 | 2017 | 2304 | 0.070 |
Why?
|
| B-Lymphocytes | 1 | 2011 | 740 | 0.070 |
Why?
|
| Genetics, Behavioral | 1 | 2006 | 22 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2012 | 1244 | 0.060 |
Why?
|
| Automation | 1 | 2006 | 112 | 0.060 |
Why?
|
| Odds Ratio | 1 | 2007 | 682 | 0.060 |
Why?
|
| Parent-Child Relations | 1 | 2006 | 79 | 0.060 |
Why?
|
| Interferon Type I | 1 | 2006 | 186 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 1180 | 0.060 |
Why?
|
| Probability | 1 | 2006 | 350 | 0.060 |
Why?
|
| Biometry | 1 | 2005 | 66 | 0.060 |
Why?
|
| Quantitative Trait, Heritable | 2 | 2020 | 124 | 0.060 |
Why?
|
| Kinetics | 1 | 2007 | 1534 | 0.060 |
Why?
|
| Genetic Drift | 1 | 2003 | 37 | 0.050 |
Why?
|
| Chromosomes | 1 | 2003 | 98 | 0.050 |
Why?
|
| Helicobacter Infections | 1 | 2003 | 37 | 0.050 |
Why?
|
| Sex Factors | 2 | 2020 | 1075 | 0.050 |
Why?
|
| Coenzyme A | 1 | 2022 | 15 | 0.050 |
Why?
|
| Aged | 3 | 2015 | 19240 | 0.050 |
Why?
|
| Amino Acids | 1 | 2022 | 246 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 2018 | 0.050 |
Why?
|
| Internet | 1 | 2003 | 323 | 0.050 |
Why?
|
| Pedigree | 2 | 2015 | 971 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2022 | 206 | 0.050 |
Why?
|
| Terminator Regions, Genetic | 2 | 2012 | 14 | 0.050 |
Why?
|
| Cells | 1 | 2020 | 32 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2024 | 700 | 0.040 |
Why?
|
| Causality | 1 | 2020 | 80 | 0.040 |
Why?
|
| Genes | 1 | 2021 | 306 | 0.040 |
Why?
|
| False Positive Reactions | 1 | 2020 | 223 | 0.040 |
Why?
|
| Research Design | 1 | 2003 | 591 | 0.040 |
Why?
|
| Middle Aged | 3 | 2015 | 26132 | 0.040 |
Why?
|
| Cholesterol | 2 | 2013 | 360 | 0.040 |
Why?
|
| Asia, Southeastern | 1 | 2019 | 16 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2020 | 274 | 0.040 |
Why?
|
| Introns | 2 | 2012 | 301 | 0.040 |
Why?
|
| Pravastatin | 2 | 2010 | 17 | 0.040 |
Why?
|
| Mutation Rate | 1 | 2019 | 49 | 0.040 |
Why?
|
| RNA, Long Noncoding | 1 | 2020 | 120 | 0.040 |
Why?
|
| Stress, Physiological | 1 | 2021 | 232 | 0.040 |
Why?
|
| Chromatin | 2 | 2012 | 403 | 0.040 |
Why?
|
| Ipomoea batatas | 1 | 2018 | 1 | 0.040 |
Why?
|
| RNA Splicing | 1 | 2020 | 156 | 0.040 |
Why?
|
| China | 1 | 2019 | 235 | 0.040 |
Why?
|
| Drosophila melanogaster | 1 | 2003 | 614 | 0.040 |
Why?
|
| Plant Breeding | 1 | 2018 | 8 | 0.040 |
Why?
|
| Methyltransferases | 1 | 2019 | 192 | 0.040 |
Why?
|
| Temperature | 1 | 2019 | 409 | 0.040 |
Why?
|
| Carcinogenesis | 1 | 2019 | 213 | 0.040 |
Why?
|
| Biodiversity | 1 | 2019 | 209 | 0.030 |
Why?
|
| Noise | 1 | 2017 | 26 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2020 | 542 | 0.030 |
Why?
|
| Risk Factors | 2 | 2020 | 5554 | 0.030 |
Why?
|
| Central African Republic | 1 | 2015 | 2 | 0.030 |
Why?
|
| Democratic Republic of the Congo | 1 | 2015 | 6 | 0.030 |
Why?
|
| Africa, Western | 1 | 2015 | 11 | 0.030 |
Why?
|
| Grassland | 1 | 2015 | 6 | 0.030 |
Why?
|
| Y Chromosome | 1 | 2015 | 29 | 0.030 |
Why?
|
| Uganda | 1 | 2015 | 38 | 0.030 |
Why?
|
| Liver | 2 | 2011 | 1211 | 0.030 |
Why?
|
| Fertility | 1 | 2015 | 116 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2006 | 2331 | 0.030 |
Why?
|
| DNA, Mitochondrial | 1 | 2015 | 189 | 0.030 |
Why?
|
| Adult | 4 | 2022 | 26810 | 0.030 |
Why?
|
| Phylogeny | 2 | 2011 | 1197 | 0.030 |
Why?
|
| Sterol Regulatory Element Binding Proteins | 1 | 2013 | 3 | 0.030 |
Why?
|
| Pregnanolone | 1 | 2012 | 8 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2018 | 2887 | 0.030 |
Why?
|
| Drosophila | 1 | 2017 | 522 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 247 | 0.030 |
Why?
|
| Human Genome Project | 1 | 2012 | 19 | 0.030 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2012 | 20 | 0.030 |
Why?
|
| Statistical Distributions | 1 | 2012 | 9 | 0.030 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2012 | 8 | 0.030 |
Why?
|
| Placebos | 1 | 2012 | 211 | 0.020 |
Why?
|
| HapMap Project | 1 | 2012 | 47 | 0.020 |
Why?
|
| Endangered Species | 1 | 2011 | 24 | 0.020 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2012 | 60 | 0.020 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2011 | 9 | 0.020 |
Why?
|
| Histones | 1 | 2014 | 333 | 0.020 |
Why?
|
| Data Mining | 1 | 2011 | 44 | 0.020 |
Why?
|
| RNA Interference | 1 | 2012 | 376 | 0.020 |
Why?
|
| Italy | 1 | 2011 | 108 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2011 | 154 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2011 | 125 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2012 | 253 | 0.020 |
Why?
|
| Child | 1 | 2022 | 7242 | 0.020 |
Why?
|
| Consensus Sequence | 1 | 2010 | 66 | 0.020 |
Why?
|
| Toll-Like Receptors | 1 | 2010 | 92 | 0.020 |
Why?
|
| Immediate-Early Proteins | 1 | 2011 | 164 | 0.020 |
Why?
|
| RNA Splice Sites | 1 | 2010 | 58 | 0.020 |
Why?
|
| Heptanoic Acids | 1 | 2010 | 71 | 0.020 |
Why?
|
| Monocytes | 1 | 2010 | 221 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2010 | 391 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2010 | 295 | 0.020 |
Why?
|
| Pyrroles | 1 | 2010 | 172 | 0.020 |
Why?
|
| Genetic Complementation Test | 1 | 2008 | 98 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2012 | 1714 | 0.020 |
Why?
|
| Sample Size | 1 | 2008 | 125 | 0.020 |
Why?
|
| Edar Receptor | 1 | 2007 | 2 | 0.020 |
Why?
|
| Antiporters | 1 | 2007 | 18 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2012 | 556 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2006 | 59 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2006 | 108 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2006 | 135 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2006 | 211 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2006 | 307 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 740 | 0.020 |
Why?
|
| Heterozygote | 1 | 2006 | 373 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2006 | 294 | 0.020 |
Why?
|
| Inflammation | 1 | 2010 | 981 | 0.010 |
Why?
|
| Pattern Recognition, Automated | 1 | 2005 | 221 | 0.010 |
Why?
|
| Polynesia | 1 | 2003 | 3 | 0.010 |
Why?
|
| Social Problems | 1 | 2003 | 10 | 0.010 |
Why?
|
| Americas | 1 | 2003 | 19 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2007 | 1315 | 0.010 |
Why?
|
| Indians, North American | 1 | 2003 | 47 | 0.010 |
Why?
|
| Asia | 1 | 2003 | 102 | 0.010 |
Why?
|
| Agriculture | 1 | 2003 | 39 | 0.010 |
Why?
|
| Genes, Bacterial | 1 | 2003 | 198 | 0.010 |
Why?
|
| Language | 1 | 2003 | 157 | 0.010 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2005 | 691 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 3024 | 0.010 |
Why?
|
| Adolescent | 1 | 2012 | 9339 | 0.010 |
Why?
|
| United States | 1 | 2011 | 7102 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2003 | 901 | 0.010 |
Why?
|